
-
Isak set for Liverpool debut in Atletico Madrid Champions League clash
-
Malawi votes in economic gloom as two presidents battle for power
-
No info in files that Epstein trafficked women to others: FBI chief
-
Stocks slip, dollar down as Fed meets on rates
-
Faith Kipyegon: Supreme Kenyan champion and role model for mothers
-
Hollywood giants sue Chinese AI firm over copyright infringement
-
Bayern's Kane keen to rekindle London rivalry against Chelsea
-
Trump sues NYT for $15 bn in latest attack on media
-
IndyCar reveals 17-race 2026 season with March opening
-
Trump heads for landmark state visit with 'friend' King Charles
-
Kipyegon sparkles, Tinch's time away pays off with world gold
-
Kerr completes Kiwi world double after Beamish tonic
-
US Fed opens key meeting after Trump aide sworn in as governor
-
Tinch crowns atypical path to top with world hurdles gold
-
Masters deal with Amazon Prime boosts US TV coverage hours
-
Thyssenkrupp says India's Jindal Steel makes bid for steel business
-
Germans turn to health apps as insurers foot the bill
-
Robert Redford, Hollywood's golden boy with a Midas touch
-
US retail sales beat expectations in August despite tariffs
-
New Zealand's Kerr wins world men's high jump gold
-
American Cordell Tinch wins world 110m hurdles gold
-
Kenya's Kipyegon wins unprecedented fourth women's world 1,500m title
-
Suspect in Kirk killing to be charged in US court
-
Cinema legend Robert Redford dead at 89
-
Europe slow to match economic rivals US, China: Draghi
-
Rugby World Cup chiefs defend handling of Berthoumieu biting incident
-
'Like failing a math test': US teen Lutkenhaus schooled at worlds
-
Philippines says one injured in China Coast Guard water cannon attack
-
Kenya court seeks UK citizen's arrest over young mother's murder
-
Malawi votes for a new president as economic crisis bites
-
Barca to stay at Johan Cruyff stadium for Getafe clash
-
'We pulled the children out in pieces': Israel pummels Gaza City
-
Stocks diverge, dollar down as Fed meets on rates
-
Zandvoort, Singapore to host F1 sprints for first time in 2026
-
Afghan man gets life in prison for jihadist knife killing in Germany
-
Shipowner linked to giant Beirut port blast held in Bulgaria
-
E. Timor police clash with protesters over plan to buy vehicles for MPs
-
Israel launches ground assault on Gaza City
-
Malawi votes in battle of two presidents as economic crisis bites
-
2025 summer was Spain's warmest on record: weather agency
-
Gout of this world? Australian teen sprinter set for first real test
-
Smoke-dried bodies could be world's 'oldest mummies': study
-
Afghan gets life in prison for jihadist knife murder in Germany
-
Trump bringing $15 bn lawsuit against New York Times
-
Juan Mata moves to Melbourne from Australian rivals
-
UN investigators say Israel committing 'genocide' in Gaza
-
Israel bombards Gaza City as UN probe accuses it of 'genocide'
-
Rubio asks Qatar to stay as mediator after Israel strike
-
Drug cheats put India Olympic bid and careers at risk
-
East Timor police fire tear gas on second day of car purchase protests
BTI | -0.21% | 55.915 | $ | |
GSK | -0.2% | 40.22 | $ | |
CMSD | 0.2% | 24.5 | $ | |
BP | 0.67% | 34.44 | $ | |
SCS | -0.21% | 16.835 | $ | |
BCC | -3.07% | 82.585 | $ | |
AZN | -0.19% | 77.905 | $ | |
RYCEF | -0.06% | 15.63 | $ | |
VOD | -0.47% | 11.755 | $ | |
BCE | -1.59% | 23.32 | $ | |
JRI | -0.47% | 13.994 | $ | |
NGG | -0.43% | 71.315 | $ | |
RIO | -0.22% | 63.58 | $ | |
RELX | -0.34% | 46.7 | $ | |
RBGPF | 0% | 77.27 | $ | |
CMSC | 0.33% | 24.4 | $ |

Vibrating pill, ingestible sensor: mini robots tackle gut disorders
A pill that vibrates to relieve constipation, a sensor that can be tracked in the gut -- medical researchers are turning to tiny robots to treat or diagnose gastrointestinal disorders.
"This is a very booming field," said Saransh Sharma, a doctoral student at the California Institute of Technology (Caltech) involved in the development of the ingestible diagnostic sensor.
"You have medical robots that are so small you can just send them inside a person using the oral passage and they can do a lot of sensing and actuation inside the gut," Sharma told AFP.
About 16 of every 100 adults in the United States suffer from symptoms of constipation, according to the US health authorities, and the number doubles for Americans over the age of 60.
Researchers at the Massachusetts Institute of Technology (MIT) and Caltech have developed an ingestible sensor that can be monitored as it travels through the digestive tract.
The device, 20 millimeters in length and eight mm in diameter, could help physicians diagnose gastrointestinal motility disorders that prevent food from moving normally through the digestive tract.
The capsule's location reveals where a slowdown is taking place.
"That gives the doctor a lot of the essential information to do a better job in the curing and the diagnosis and the treatment plan," Sharma said.
The sensor could also provide an alternative to invasive procedures such as endoscopy or other diagnostic techniques such as nuclear imaging, X-rays or catheters.
It has been tested on pigs and the team behind the research hopes to eventually obtain the approval of the US Food and Drug Administration for human clinical trials.
"If we can demonstrate a device inside large animals like pigs up to a very high confidence, we can say that it will scale very well in human anatomy as well," Sharma said.
The authors published the results of their research on Monday in the journal Nature Electronics.
They said the sensor works by detecting a magnetic field produced by an electromagnetic coil located outside of the body.
The strength of the magnetic field varies with distance from the coil and the sensor's position within the digestive tract can be calculated to within millimeters based on measurement of the magnetic field.
- Vibrating capsule -
While the ingestible sensor is still in the development phase, an Israeli company called Vibrant Gastro recently began marketing a vibrating capsule in the United States designed to relieve chronic constipation.
The drug-free Vibrant capsule is intended for constipation sufferers who have not received bowel relief after a month of laxative treatments. It has been FDA-approved.
In a Phase 3 clinical trial of 300 people, participants who took Vibrant had bowel movements significantly more frequently than those who took a placebo.
The Vibrant capsule produces gentle vibrations to stimulate the colon and increases the number and frequency of bowel movements, according to the manufacturer.
Y.Kobayashi--AMWN